Bernd Höppe

12.3k total citations
179 papers, 6.9k citations indexed

About

Bernd Höppe is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Bernd Höppe has authored 179 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Pulmonary and Respiratory Medicine, 73 papers in Pediatrics, Perinatology and Child Health and 58 papers in Molecular Biology. Recurrent topics in Bernd Höppe's work include Kidney Stones and Urolithiasis Treatments (109 papers), Pediatric Urology and Nephrology Studies (58 papers) and Biomedical Research and Pathophysiology (41 papers). Bernd Höppe is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (109 papers), Pediatric Urology and Nephrology Studies (58 papers) and Biomedical Research and Pathophysiology (41 papers). Bernd Höppe collaborates with scholars based in Germany, United States and Switzerland. Bernd Höppe's co-authors include Bodo B. Beck, Ernst Leumann, Markus J. Kemper, Albrecht Hesse, Dawn S. Milliner, Craig B. Langman, Jaap W. Groothoff, Sandra Habbig, Christoph Licht and Peter F. Zipfel and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Bernd Höppe

177 papers receiving 6.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernd Höppe Germany 46 4.0k 2.5k 2.1k 1.7k 1.4k 179 6.9k
Dawn S. Milliner United States 44 3.7k 0.9× 2.3k 0.9× 2.1k 1.0× 1.5k 0.9× 1.5k 1.1× 134 6.7k
Francesco Scolari Italy 42 1.6k 0.4× 1.8k 0.7× 617 0.3× 3.9k 2.3× 1.1k 0.8× 166 7.0k
Helen Liapis United States 45 1.4k 0.3× 2.5k 1.0× 478 0.2× 2.2k 1.3× 672 0.5× 145 6.6k
Michael D. Hughson United States 41 1.2k 0.3× 1.7k 0.7× 2.3k 1.1× 1.4k 0.9× 245 0.2× 109 5.6k
Jay Bernstein United States 43 1.4k 0.3× 1.8k 0.7× 1.2k 0.6× 1.2k 0.7× 367 0.3× 151 5.4k
S. Michael Mauer United States 52 1.2k 0.3× 2.0k 0.8× 1.1k 0.5× 3.6k 2.2× 572 0.4× 165 9.8k
Justine Bacchetta France 33 1.0k 0.3× 883 0.3× 930 0.5× 2.1k 1.3× 1.1k 0.8× 270 4.8k
A Bensman France 33 752 0.2× 944 0.4× 630 0.3× 1.3k 0.8× 432 0.3× 133 3.3k
Luisa Murer Italy 35 485 0.1× 1.0k 0.4× 701 0.3× 1.6k 1.0× 472 0.3× 121 3.7k
Marie C. Hogan United States 40 1.0k 0.3× 2.5k 1.0× 691 0.3× 1.5k 0.9× 1.1k 0.8× 109 5.8k

Countries citing papers authored by Bernd Höppe

Since Specialization
Citations

This map shows the geographic impact of Bernd Höppe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Höppe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Höppe more than expected).

Fields of papers citing papers by Bernd Höppe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Höppe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Höppe. The network helps show where Bernd Höppe may publish in the future.

Co-authorship network of co-authors of Bernd Höppe

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Höppe. A scholar is included among the top collaborators of Bernd Höppe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Höppe. Bernd Höppe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Höppe, Bernd, et al.. (2024). Effective Newborn Screening for Type 1 and 3 Primary Hyperoxaluria. Kidney International Reports. 10(1). 177–183. 2 indexed citations
2.
Groothoff, Jaap W., Anne‐Laure Sellier‐Leclerc, Justine Bacchetta, et al.. (2024). Nedosiran Safety and Efficacy in PH1: Interim Analysis of PHYOX3. Kidney International Reports. 9(5). 1387–1396. 11 indexed citations
3.
Höppe, Bernd & Cristina Martín-Higueras. (2022). Improving Treatment Options for Primary Hyperoxaluria. Drugs. 82(10). 1077–1094. 22 indexed citations
4.
Höppe, Bernd, et al.. (2022). Nephrolithiasis und Nephrokalzinose bei Kindern und Jugendlichen. PubMed. 61(10). 1099–1109.
5.
Höppe, Bernd, et al.. (2020). Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study. Nephrology Dialysis Transplantation. 36(8). 1464–1473. 29 indexed citations
6.
Acquaviva, Cécile, et al.. (2020). Plasma oxalate: comparison of methodologies. Urolithiasis. 48(6). 473–480. 14 indexed citations
7.
Torres, Jacob A., Louis M. Lin, Xiaofang Wang, et al.. (2019). Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease. Journal of Clinical Investigation. 129(10). 4506–4522. 59 indexed citations
8.
Siener, Roswitha, et al.. (2018). Metabolic profile and impact of diet in patients with primary hyperoxaluria. International Urology and Nephrology. 50(9). 1583–1589. 17 indexed citations
9.
Halbritter, Jan, et al.. (2018). Update on Hereditary Kidney Stone Disease and Introduction of a New Clinical Patient Registry in Germany. Frontiers in Pediatrics. 6. 47–47. 20 indexed citations
10.
Brooks, Ellen R., Bernd Höppe, Dawn S. Milliner, et al.. (2016). Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria. American Journal of Nephrology. 43(4). 293–303. 10 indexed citations
11.
Schalk, Gesa, Michael Kirschfink, Cyrill Wehling, et al.. (2015). A complicated case of atypical hemolytic uremic syndrome with frequent relapses under eculizumab. Pediatric Nephrology. 30(6). 1039–1042. 13 indexed citations
12.
Siener, Roswitha, et al.. (2013). Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria. Journal of Translational Medicine. 11(1). 306–306. 54 indexed citations
13.
Sikora, Przemysław, Gerd E. Von Unruh, Bodo B. Beck, et al.. (2008). [13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria. Kidney International. 73(10). 1181–1186. 44 indexed citations
14.
Müller‐Berghaus, Jan, Markus J. Kemper, Bernd Höppe, et al.. (2008). The clinical course of steroid-sensitive childhood nephrotic syndrome is associated with a functional IL12B promoter polymorphism. Nephrology Dialysis Transplantation. 23(12). 3841–3844. 9 indexed citations
15.
Höppe, Bernd, et al.. (2006). Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney International. 70(7). 1305–1311. 147 indexed citations
16.
Laube, Norbert, Bernd Höppe, & Albrecht Hesse. (2005). Problems in the investigation of urine from patients suffering from primary hyperoxaluria type 1. Urological Research. 33(5). 394–397. 3 indexed citations
17.
Licht, Christoph, et al.. (2004). Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS). Kidney International. 66(3). 955–958. 44 indexed citations
18.
Höppe, Bernd, et al.. (1998). Simultaneous determination of oxalate, citrate and sulfate in children's plasma with ion chromatography: Technical Note. Kidney International. 53(5). 1348–1352. 45 indexed citations
19.
Höppe, Bernd, Christopher J. Danpure, Gill Rumsby, et al.. (1997). A vertical (pseudodominant) pattern of inheritance in the autosomal recessive disease primary hyperoxaluria type 1: Lack of relationship between genotype, enzymic phenotype, and disease severity. American Journal of Kidney Diseases. 29(1). 36–44. 53 indexed citations
20.
Höppe, Bernd. (1996). Spinal epidural abscess: The nurse's role in early detection and intervention. Heart & Lung. 25(6). 463–466. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dawn S. Milliner Breakdown of academic impact, for papers by Francesco Scolari Breakdown of academic impact, for papers by Helen Liapis Breakdown of academic impact, for papers by Michael D. Hughson Breakdown of academic impact, for papers by Jay Bernstein Breakdown of academic impact, for papers by S. Michael Mauer Breakdown of academic impact, for papers by Justine Bacchetta Breakdown of academic impact, for papers by A Bensman Breakdown of academic impact, for papers by Luisa Murer Breakdown of academic impact, for papers by Marie C. Hogan
Rankless by CCL
2026